Technical Analysis for KRYS - Krystal Biotech, Inc.

Grade Last Price % Change Price Change
grade B 25.02 4.25% 1.02
KRYS closed up 4.25 percent on Friday, March 22, 2019, on 1.93 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical KRYS trend table...

Date Alert Name Type % Chg
Mar 22 MACD Bullish Centerline Cross Bullish 0.00%
Mar 22 Stochastic Reached Overbought Strength 0.00%
Mar 22 Above Upper BB Strength 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 20 DMA Support Bullish 4.25%
Mar 21 Crossed Above 50 DMA Bullish 4.25%
Mar 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 12.96%
Mar 20 20 DMA Support Bullish 12.96%
Mar 20 MACD Bullish Signal Line Cross Bullish 12.96%

Older signals for KRYS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.
Medicine Rare Diseases Gene Therapy Medical Genetics Genetic Genealogy Genodermatoses Herpes Simplex Virus Epidermolysis Bullosa Itchiness
Is KRYS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.75
52 Week Low 8.91
Average Volume 59,220
200-Day Moving Average 19.6161
50-Day Moving Average 22.8404
20-Day Moving Average 22.2433
10-Day Moving Average 21.723
Average True Range 1.6432
ADX 22.31
+DI 24.9403
-DI 17.8861
Chandelier Exit (Long, 3 ATRs ) 20.2204
Chandelier Exit (Short, 3 ATRs ) 23.4296
Upper Bollinger Band 24.8347
Lower Bollinger Band 19.6519
Percent B (%b) 1.04
BandWidth 23.300499
MACD Line 0.0794
MACD Signal Line -0.2757
MACD Histogram 0.3551
Fundamentals Value
Market Cap 241.28 Million
Num Shares 9.64 Million
EPS -0.63
Price-to-Earnings (P/E) Ratio -39.71
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.51
Resistance 3 (R3) 27.28 26.21 27.10
Resistance 2 (R2) 26.21 25.58 26.33 26.96
Resistance 1 (R1) 25.62 25.19 25.92 25.85 26.82
Pivot Point 24.55 24.55 24.70 24.67 24.55
Support 1 (S1) 23.96 23.92 24.25 24.19 23.22
Support 2 (S2) 22.89 23.53 23.01 23.08
Support 3 (S3) 22.29 22.89 22.94
Support 4 (S4) 22.53